Detailed price information for Crinetics Pharmaceuticals Inc (CRNX-Q) from The Globe and Mail including charting and trades.
Crinetics Pharmaceuticals' stock has surged after FDA approval of Palsonify for acromegaly. Click here to read the latest ...
Berry Genomics plans to expand its sequencing capability to clinical assays like congenital adrenal hyperplasia and spinal muscular atrophy.
Every child deserves a healthy start in life—and for many Filipino families, that begins with a small prick on a newborn’s ...
Detailed price information for Neurocrine Bioscienc (NBIX-Q) from The Globe and Mail including charting and trades.
Analysts are estimating that Neurocrine Biosciences will report an earnings per share (EPS) of $1.87. Neurocrine Biosciences ...
Neurocrine Biosciences has penned a deal with China’s TransThera Sciences potentially worth more than $880 million in biobucks for inhibitors aimed at a red-hot inflammation target. | Neurocrine ...
Thailand has made history by recognising same-sex marriage, affirming the right of adults to love and marry freely. This will rightly be celebrated as a triumph for equality and human dignity. Yet, in ...
SAN DIEGO - Neurocrine Biosciences, Inc. (NASDAQ:NBIX) shares rose 3.3% after the neuroscience-focused biopharmaceutical company reported third-quarter financial results that significantly exceeded ...
Facial hair is often viewed as an irritant by most ladies. While facial hair is a normal part of a woman’s body, excessive growth of it is ca ...
Crinetics Pharma (($CRNX)) announced an update on their ongoing clinical study. Study Overview: Crinetics Pharmaceuticals is conducting a Phase ...
TipRanks on MSN
Crinetics Pharma’s New Study on Atumelnant: A Potential Game-Changer for CAH Treatment
Crinetics Pharma (($CRNX)) announced an update on their ongoing clinical study. Study Overview: Crinetics Pharmaceuticals is conducting a study ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results